Associate, Asset Acquisition, GondolaBio

Job Description

Job Description

Description : About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

About BridgeBio

BridgeBio is a commercial stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company built a portfolio of 22+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, pulmonology, renal disease, and genetic dermatology, with three approved drugs. We have U.S. offices in San Francisco, Palo Alto, and Raleigh. We also have international offices in Montreal, Canada, and Switzerland.

Who You Are

GondolaBio’s Asset Acquisition team is seeking an Associate to help us define our new programs. We are looking for ambitious scientists who’d like to contribute at the intersection of science and business. Our team is responsible for finding, evaluating, and determining which therapeutic ideas GondolaBio will pursue, with an emphasis on evaluation of the scientific rationale behind therapeutic strategies. The team works closely with GondolaBio’s Investment Committee, which is composed of veteran drug developers and renowned academic scientists. Across the BridgeBio ecosystem, we have spearheaded partnerships with academic and industry groups to create, fund, and operate >

30 new drug development programs. As a key member of the team, this position will help set the culture and business development of the company and will be the face of the organization.

Requirements : Responsibilities

• Identify promising new preclinical or early clinical stage programs to treat genetically driven diseases through deep engagement with the literature, academic and industry experts, and internal development efforts
• Deeply evaluate all aspects of a potential therapeutic program—from genetic rationale and pre-clinical evidence all the way to the development plan and clinical trial design
• Advocate for those that fit our goal of targeting the genetic source of a disease by building a scientific and business case for each potential investment
• Interface with leading academics, patient advocacy groups, biotechs, and entrepreneurs
• Lead internal discussions with management and the Investment Committee
• Establish a focused investment strategy and follow through to identify new investment opportunities
• Coordinate and work with a talented team of internal subject-matter experts—including clinical, commercial, and disease experts—to dive as deeply as needed for each project

Education and Experience & Skills Requirements

No matter your role, successful team members are :

What We Offer

The base pay range for this position is $130,000 to $170,000 per year. The actual compensation offered will be determined based on a number of job-related factors, including experience, skills, qualifications, and location. A bonus plan and equity will also be offered.